Business
Press Release Jul 29 2022
Alembic Pharmaceuticals Limited has informed the Exchange about press release dated 29-Jul-2022 titled Alembic Pharmaceuticals announces its wholly owned subsidiary, Aleor Dermaceuticals Limited receives USFDA Final Approval for Diclofenac Sodium Topical Gel, 3%
About this update from Alembic Pharmaceuticals Limited
[{"type":"text","content":" Alembic Pharmaceuticals Limited has informed the Exchange about press release dated 29-Jul-2022 titled Alembic Pharmaceuticals announces its wholly owned subsidiary, Aleor Dermaceuticals Limited receives USFDA Final Approval for Diclofenac Sodium Topical Gel, 3% View Attachment","length":453,"tagName":"div"}]